Big Pharma is profiting from fake THC/CBD drugs. Some cannabis legalization advocates say the marketing of those drugs is part of what's driving the crackdown on pot.
"The biggest problem with this scandal isn't that Cambridge Analytica is shady -- it's that Facebook is," argues one journalist.
Michael Levitin is an editor at the Occupied Wall Street Journal and Occupy.com. His freelance work has appeared in Newsweek, The Los Angeles Times and other publications.